Identification of urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) as therapeutic targets for pancreatic cancer.

被引：0
|
作者：
Della Croce, K
Han, H
Beroza, P
Bearss, DJ
von Hoff, DD
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[2] Telik Inc, S San Francisco, CA USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72
引用
收藏
页码：3668S / 3668S
页数：1
相关论文
共 50 条
  • [21] Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer
    Asuthkar, Swapna
    Stepanova, Victoria
    Lebedeva, Tatiana
    Holterman, AiXuan L.
    Estes, Norman
    Cines, Douglas B.
    Rao, Jasti S.
    Gondi, Christopher S.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24 (17) : 2620 - 2632
  • [22] Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
    Mahmood, Niaz
    Mihalcioiu, Catalin
    Rabbani, Shafaat A.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [23] Modulation of NK cell integrins by urokinase plasminogen activator receptor (uPAR)
    Gellert, GC
    Kitson, RP
    Goldfarb, RH
    FASEB JOURNAL, 2002, 16 (05): : A1212 - A1212
  • [24] THE RECEPTOR FOR UROKINASE-PLASMINOGEN ACTIVATOR
    BLASI, F
    STOPPELLI, MP
    CUBELLIS, MV
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, 32 (03) : 179 - 186
  • [25] THE RECEPTOR FOR THE UROKINASE PLASMINOGEN-ACTIVATOR
    BLASI, F
    STOPPELLI, P
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 236 - 236
  • [26] Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides
    Burgle, M
    Koppitz, M
    Riemer, C
    Kessler, H
    Konig, B
    Weidle, UH
    Kellermann, J
    Lottspeich, F
    Graeff, H
    Schmitt, M
    Goretzki, L
    Reuning, U
    Wilhelm, O
    Magdolen, V
    BIOLOGICAL CHEMISTRY, 1997, 378 (3-4) : 231 - 237
  • [27] Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis
    Leonardi, A
    Brun, P
    Sartori, MT
    Cortivo, R
    DeDominicis, C
    Saggiorato, G
    Abatangelo, G
    Secchi, AG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (04) : 1364 - 1370
  • [28] Urokinase-type plasminogen activator (uPA) and its receptor (uPAR):: Development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo
    Reuning, U
    Sperl, S
    Kopitz, C
    Kessler, H
    Krüger, A
    Schmitt, M
    Magdolen, V
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (19) : 1529 - 1543
  • [29] Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer
    de Bock, CE
    Wang, Y
    MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) : 13 - 39
  • [30] Structural studies on the urokinase plasminogen activator receptor (uPAR), a key mediator of cancer invasiveness
    Iuzzolino, L.
    Andolfo, A.
    Sidenius, N.
    Blasi, F.
    Degano, M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2004, 60 : S111 - S111
12345